@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-VD31CPL8-G skos:prefLabel "Ergotamines"@fr, "Ergotamines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-SP2F0195-R . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-SP2F0195-R mesh:allowableQualifier jvr:-T9HQD7ST-J, jvr:-D0F21513-5, jvr:-R3QWLHRG-V, jvr:-Q3979798-W, jvr:-G30ZJ446-J, jvr:-NB0XHT3S-N, jvr:-R0ZCQ8X6-J, jvr:-SBNWSM1T-R, jvr:-H7K65Q8S-Z, jvr:-G4R176S9-J, jvr:-L6C0XPHT-4, jvr:-NHL3D2X0-S, jvr:-THHNVC7V-3, jvr:-CB30NGKB-3, jvr:-FWD2BGQ0-9, jvr:-NFTHND7Q-8, jvr:-M63HSDM7-1, jvr:-S0CS1X5R-5, jvr:-XV06LPML-W, jvr:-TJHVZCRZ-0, jvr:-HQRFT0C6-B, jvr:-W6SQV79N-S, jvr:-NKM836P1-M, jvr:-BT300B3G-Q, jvr:-WK5F724J-1 ; skos:hiddenLabel "Mésylate d'alpha-dihydroergocryptine"@fr, "Dihydroergocryptine Monomesylate"@en, "Almirid"@en, "Mésilate d'alpha-dihydroergocryptine"@fr, "Cripar"@en, "Dihydroergocryptine Mesylate"@en, "Dihydroergokryptine Monomesylate"@en, "Dihydroergokryptine Mesylate"@en ; a mesh:Descriptor, skos:Concept ; skos:altLabel "Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl"@fr, "Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl"@en, "29261-93-6 (Dihydroergocryptine mesylate)"@fr, "29261-93-6 (Dihydroergocryptine mesylate)"@en, "14271-05-7 (Dihydroergocryptine monomesylate)"@fr, "14271-05-7 (Dihydroergocryptine monomesylate)"@en, "67V3FSL2GL"@fr, "67V3FSL2GL"@en, "25447-66-9"@fr, "25447-66-9"@en ; mesh:pharmacologicalAction jvr:-C9JFSVWC-Q, jvr:-K9FBN5C5-1 ; skos:prefLabel "alpha-Dihydroergocryptine"@fr, "Dihydroergocryptine"@en ; skos:definition "A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position and an alpha-isobutyl sidechain at 5'alpha position of the molecule."@en ; owl:sameAs ; dc:established "2002-01-01"^^xsd:date ; skos:related jvr:-C2JNMX6F-D ; dc:created "2001-07-25"^^xsd:date ; skos:broader jvr:-VD31CPL8-G ; skos:inScheme jvr: ; dc:modified "2017-05-24"^^xsd:date . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-C2JNMX6F-D skos:prefLabel "Dihydroergotoxine"@fr, "Dihydroergotoxine"@en ; a mesh:Descriptor, skos:Concept ; skos:related jvr:-SP2F0195-R . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-K9FBN5C5-1 skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ; a mesh:Descriptor, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-C9JFSVWC-Q skos:prefLabel "Agonistes de la dopamine"@fr, "Dopamine Agonists"@en ; a mesh:Descriptor, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .